Michelle Doig

Michelle Doig

Oprichter bij OMEGA ALPHA SPAC
52 jaar
Finance
Health Technology
Consumer Services

Profiel

Michelle Doig is the founder of Omega Alpha SPAC, founded in 2020, serving as President & Director.
Current jobs include Independent Director at Bridgebio Oncology Therapeutics, Inc. since 2024; Director at Artios Pharma Ltd. since 2021; Director at Nuvation Bio Operating Co., Inc.; and Partner & Head-Corporate Development at Omega Fund Management LLC since 2016.
Former jobs include Director-Corporate Finance at Third Rock Ventures LLC from 2013 to 2016; Director at Nuvation Bio, Inc. from 2019 to 2021; Director at Bridgebio Oncology Therapeutics, Inc. from 2025 to 2026; Associate at Lehman Brothers, Inc. from 2001 to 2002; Analyst at Morgan Stanley from 1996 to 1998; Principal at Abingworth LLP from 2004 to 2013; Associate at J.P.
Morgan & Co., Inc. (Delaware) from 1998 to 2001; and Manager at Student Works Management Program from 1993 to 1995.
Education includes undergraduate studies at Richard Ivey School of Business.

Actieve functies van Michelle Doig

BedrijvenFunctieBegin
OMEGA ALPHA SPAC Oprichter 01-11-2020
Private Equity Investor 01-01-2016
Directeur/Bestuurslid -
Directeur/Bestuurslid 01-07-2021

Eerdere bekende functies van Michelle Doig

BedrijvenFunctieEinde
NUVATION BIO INC. Directeur/Bestuurslid 31-07-2021
Private Equity Investor 31-12-2016
Corporate Officer/Principal 01-11-2013
Corporate Officer/Principal 01-01-2002
Ervaring van Michelle Doig in detail bekijken

Opleiding van Michelle Doig

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

81

Eerstegraads connecties

11

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit11

Finance

Finance

Finance

Finance

Finance

Consumer Services

Health Technology

Finance

Health Technology

Finance

Health Technology

  1. Beurs
  2. Insiders
  3. Michelle Doig